Body composition variation and impact of low skeletal muscle mass in patients with advanced medullary thyroid carcinoma treated with vandetanib: results from a placebo-controlled study (Q44770320)
Jump to navigation
Jump to search
scientific article published on 29 March 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Body composition variation and impact of low skeletal muscle mass in patients with advanced medullary thyroid carcinoma treated with vandetanib: results from a placebo-controlled study |
scientific article published on 29 March 2013 |
Statements
1 reference
Body composition variation and impact of low skeletal muscle mass in patients with advanced medullary thyroid carcinoma treated with vandetanib: results from a placebo-controlled study (English)
1 reference
1 reference
Sophie Leboulleux
1 reference
Eric Baudin
1 reference
Martin Schlumberger
1 reference
Marie-Hélène Massicotte
1 reference
Alain Deroussent
1 reference
Sami Antoun
1 reference
29 March 2013
1 reference
1 reference
98
1 reference
6
1 reference
2401-2408
1 reference
Identifiers
1 reference
1 reference